Expression of Fas/Apo-1 (CD95) and apoptosis in tumor cells from patients with plasma cell disorders

Blood

Volumn 86, Issue 5, 1995, Pages 1939-1945

  Hata, Hiroyuki ^a   Matsuzaki, Hiromitsu ^b   Takeya, Motohiro ^b   Yoshida, Minoru ^b   Sonoki, Takashi ^b   Nagasaki, Akitoshi ^b   Kuribayashi, Noriomi ^b   Kawano, Fumio ^b   Takatsuki, Kiyoshi ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PLASMA CELL; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL;

EID: 0029163282     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.5.1939.bloodjournal8651939     Document Type: Article

References (21)

1. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
2. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
3. Trauth BC, Klas C, Peters AMJ, Matzku S, Moeller P, Falk W, Debatin KM, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301, 1989
4. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314, 1992
5. 2+-independent T cell-mediated cytotoxicity. J Exp Med 177:195, 1993
6. Fluckiger AC, Durand I, Banchereau J: Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 179:91, 1994
7. Mcconkey DJ, Santelises MA, Hartzell P, Erikson I, Mellstedt H, Orrenius S, Jondal M: Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. J Immunol 146:1072, 1991
8. Nishihara T, Okahashi N, Ueda N: Activin A induces apoptotic cell death. Biochem Biophys Res Commun 197:985, 1993
9. Barlogie B, Smallwood L, Smith T, Alexanian L: High serum levels of lactic dehydrogenase identify a high grade lymphoma-like myeloma. Ann Intern Med 110:521, 1989
10. Matsuzaki H, Hata H, Takeya M, Takatsuki K: Establishment and characterization of an amylase-producing human myeloma cell line. Blood 72:978, 1988
11. Hata H, Matsuzaki H, Sonoki T, Takemoto S, Kuribayashi N, Nagasaki A, Takatsuki K: Establishment of a CD45-positive immature plasma cell line from an aggressive myeloma with high serum lactate dehydrogenase. Leukemia 8:1768, 1994
12. Ohtsuki T, Yawata Y, Wada H, Sugihara T, Mori M, Namba M: Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;1q32). Br J Haematol 73:199, 1989
13. Matsuzaki H, Hata H, Asou N, Suzushima H, Akahoshi Y, Yoshida M, Nagakura S, Ishii T, Sanada I, Takatsuki K: Establishment and characterization of acute B-cell lymphocytic leukemia cell line showing (8;14) and (14;18) chromosome translocation. Acta Haematol 84:156, 1990
14. Facchinetti A, Tessarollo L, Mazzocchi M, Kingston R, Collavo D, Biasi G: An improved method for the detection of DNA fragmentation. J Immunol Methods 136:125, 1991
15. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
16. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S: Human Fas ligand: Gene structure, chromosome location and species specificity. Int Immunol 6:1567, 1994
17. Klein B, Wijdenes J, Zhang XG, Jourdan M, Boiron JM, Brochier J, Liautard J, Merlin M, Clement C, Fournier BM, Lu ZY, Mannoni P, Sany J, Bataille R: Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 78:1198, 1991
18. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N: Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201, 1994
19. Akiyama N, Tsuruta H, Sasaki H, Sakamoto H, Hamaguchi M, Ohmura Y, Seto M, Ueda R, Hirai H, Yazaki Y, Sugimura T, Terada M: Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32). Cancer Res 54:377, 1994
20. Kawano MM, Huang N, Harada H, Harada Y, Sakai A, Tanaka H, Iwato K, Kuramoto A: Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood 82:564, 1993
21. Sugihara H, Kanakura Y, Furitsu T, Ishihara K, Oritani K, Ikeda H, Kitayama H, Ishikawa J, Hashimoto K, Kanayama Y, Matsuzawa Y: Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5. J Exp Med 179:1757, 1994